carbidopa has been researched along with Liver Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhutia, YD; Ganapathy, V; Gonchigar, S; Miyauchi, S; Ogura, J; Shimono, K; Yang, S | 1 |
| Cowie, F; Grosset, DG; Watson-Fargie, T; White, J | 1 |
| Frakolaki, E; Gkogkosi, P; Paspaltsis, I; Siaterli, MZ; Sklaviadis, T; Vassilacopoulou, D; Vassilaki, N; Vassiliou, AG | 1 |
| Bergström, M; Eriksson, B; Långström, B; Lu, L; Oberg, K; Orlefors, H; Sundin, A | 1 |
1 trial(s) available for carbidopa and Liver Neoplasms
| Article | Year |
|---|---|
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography.
Topics: 5-Hydroxytryptophan; Carbidopa; Carbon Radioisotopes; Carcinoid Tumor; Female; Humans; Image Enhancement; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
3 other study(ies) available for carbidopa and Liver Neoplasms
| Article | Year |
|---|---|
Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy.
Topics: Active Transport, Cell Nucleus; Aryl Hydrocarbon Hydroxylases; Carbidopa; Cell Nucleus; Hep G2 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Liver Neoplasms; Neoplasm Proteins; Pancreatic Neoplasms; Receptors, Aryl Hydrocarbon; Signal Transduction | 2017 |
Possible modulation of concurrent Parkinson's disease in the management of metastatic GIST: a review of two cases.
Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Levodopa; Liver Neoplasms; Male; Parkinson Disease; Severity of Illness Index; Stomach Neoplasms | 2018 |
L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Carcinoma, Hepatocellular; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neuroblastoma; Peptide Fragments; Peptide Library; Phosphatidylinositol 3-Kinases; Tumor Cells, Cultured | 2019 |